Jörg Hartkamp

711 total citations
16 papers, 541 citations indexed

About

Jörg Hartkamp is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jörg Hartkamp has authored 16 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Immunology. Recurrent topics in Jörg Hartkamp's work include Renal and related cancers (4 papers), Cell death mechanisms and regulation (3 papers) and PARP inhibition in cancer therapy (3 papers). Jörg Hartkamp is often cited by papers focused on Renal and related cancers (4 papers), Cell death mechanisms and regulation (3 papers) and PARP inhibition in cancer therapy (3 papers). Jörg Hartkamp collaborates with scholars based in Germany, United Kingdom and United States. Jörg Hartkamp's co-authors include Stefan G. E. Roberts, Ulf R. Rapp, Jakob Troppmair, Brian Carpenter, Julian R. Sampson, Anja Jaeschke, Richard F. Lamb, Takahiro Nobukuni, Wendy Wassyng Roworth and George Thomas and has published in prestigious journals such as The Journal of Cell Biology, Molecular Cell and Oncogene.

In The Last Decade

Jörg Hartkamp

16 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jörg Hartkamp Germany	11	426	130	85	66	63	16	541
Vijay Menon United States	14	367 0.9×	139 1.1×	93 1.1×	75 1.1×	82 1.3×	28	593
Archana Mukhopadhyay United States	6	433 1.0×	69 0.5×	62 0.7×	51 0.8×	42 0.7×	10	510
Kristen Bisanz United States	6	287 0.7×	124 1.0×	32 0.4×	37 0.6×	58 0.9×	7	389
Maurice Reimann Germany	10	385 0.9×	206 1.6×	146 1.7×	126 1.9×	77 1.2×	14	563
Kiran Nakka Canada	13	500 1.2×	82 0.6×	43 0.5×	67 1.0×	148 2.3×	18	642
S Bryce United Kingdom	9	335 0.8×	177 1.4×	72 0.8×	63 1.0×	96 1.5×	13	535
Boyko S. Atanassov United States	12	618 1.5×	195 1.5×	40 0.5×	66 1.0×	90 1.4×	20	729
Kim Moran‐Jones Australia	13	465 1.1×	63 0.5×	31 0.4×	36 0.5×	92 1.5×	16	562
Paola Torreri Italy	14	308 0.7×	53 0.4×	63 0.7×	111 1.7×	44 0.7×	21	459
Angen Liu United States	6	422 1.0×	95 0.7×	35 0.4×	71 1.1×	94 1.5×	6	515

Countries citing papers authored by Jörg Hartkamp

Since Specialization

Citations

This map shows the geographic impact of Jörg Hartkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Hartkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Hartkamp more than expected).

Fields of papers citing papers by Jörg Hartkamp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Hartkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Hartkamp. The network helps show where Jörg Hartkamp may publish in the future.

Co-authorship network of co-authors of Jörg Hartkamp

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Hartkamp. A scholar is included among the top collaborators of Jörg Hartkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Hartkamp. Jörg Hartkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Polla, D.L., Sebastiano Di Bucchianico, Steffen Fischer, et al.. (2023). Neuronal progenitor cells-based metabolomics study reveals dysregulated lipid metabolism and identifies putative biomarkers for CLN6 disease. Scientific Reports. 13(1). 18550–18550. 4 indexed citations

Viceconte, Nikenza, Christian Schölz, Axel Schubert, et al.. (2021). Comparison of SARS-CoV-2 Antigen Tests in Asymptomatic Testing of Passengers at German Airports under Time Constraints: Application of Three Different Antigen Test Formats. COVID. 1(3). 546–554. 1 indexed citations

Guo, Haihong, et al.. (2019). PAR-4 overcomes chemo-resistance in breast cancer cells by antagonizing cIAP1. Scientific Reports. 9(1). 8755–8755. 17 indexed citations

Nathan, Abinaya, Nicole Kiweler, Carol Stocking, et al.. (2018). Loss of Wilms tumor 1 protein is a marker for apoptosis in response to replicative stress in leukemic cells. Archives of Toxicology. 92(6). 2119–2135. 13 indexed citations

Hendriks, Christine M. M., et al.. (2017). Sulfoximines as ATR inhibitors: Analogs of VE-821. Bioorganic & Medicinal Chemistry Letters. 27(12). 2659–2662. 22 indexed citations

Hartkamp, Jörg, et al.. (2016). Assessment of HDACi-Induced Protein Cleavage by Caspases. Methods in molecular biology. 1510. 11–22. 1 indexed citations

Kappes, Ferdinand, Dirk Fahrenkamp, Gerhard Müller‐Newen, et al.. (2014). Caspase-8-mediated PAR-4 cleavage is required for TNFα-induced apoptosis. Oncotarget. 5(10). 2988–2998. 22 indexed citations

Hartkamp, Jörg, Patricia Verheugd, Alexandra Forst, et al.. (2013). Caspase‐dependent cleavage of the mono‐ADP‐ribosyltransferase ARTD10 interferes with its pro‐apoptotic function. FEBS Journal. 280(5). 1330–1343. 49 indexed citations

Krämer, Oliver H., Roland H. Stauber, Gesine Bug, Jörg Hartkamp, & Shirley K. Knauer. (2012). SIAH proteins: critical roles in leukemogenesis. Leukemia. 27(4). 792–802. 44 indexed citations

10.

Hartkamp, Jörg & Stefan G. E. Roberts. (2010). HtrA2, taming the oncogenic activities of WT1. Cell Cycle. 9(13). 2508–2514. 8 indexed citations

11.

Hartkamp, Jörg, Brian Carpenter, & Stefan G. E. Roberts. (2010). The Wilms' Tumor Suppressor Protein WT1 Is Processed by the Serine Protease HtrA2/Omi. Molecular Cell. 37(2). 159–171. 63 indexed citations

12.

Hartkamp, Jörg & Stefan G. E. Roberts. (2008). The role of the Wilms' tumour-suppressor protein WT1 in apoptosis. Biochemical Society Transactions. 36(4). 629–631. 24 indexed citations

13.

Hartkamp, Jörg, Marca H. M. Wauben, Tim Magnus, et al.. (2002). Truncation of the neuritogenic peptide bP2(60–70) results in the generation of altered peptide ligands with the potential to interfere with T cell activation. Journal of Neuroimmunology. 129(1-2). 97–105. 5 indexed citations

14.

Jaeschke, Anja, Jörg Hartkamp, Wendy Wassyng Roworth, et al.. (2002). Tuberous sclerosis complex tumor suppressor–mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. The Journal of Cell Biology. 159(2). 217–224. 167 indexed citations

15.

Hartkamp, Jörg, Jakob Troppmair, & Ulf R. Rapp. (1999). The JNK/SAPK activator mixed lineage kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent fashion.. PubMed. 59(9). 2195–202. 57 indexed citations

16.

Troppmair, Jakob, Jörg Hartkamp, & Ulf R. Rapp. (1998). Activation of NF-κB by oncogenic Raf in HEK 293 cells occurs through autocrine recruitment of the stress kinase cascade. Oncogene. 17(6). 685–690. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact